KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Idexx Laboratories (IDXX) Debt to Equity (2016 - 2025)

Idexx Laboratories has reported Debt to Equity over the past 17 years, most recently at $0.28 for Q4 2025.

  • Quarterly results put Debt to Equity at $0.28 for Q4 2025, down 27.62% from a year ago — trailing twelve months through Dec 2025 was $0.28 (down 27.62% YoY), and the annual figure for FY2025 was $0.28, down 27.62%.
  • Debt to Equity for Q4 2025 was $0.28 at Idexx Laboratories, down from $0.34 in the prior quarter.
  • Over the last five years, Debt to Equity for IDXX hit a ceiling of $2.93 in Q3 2022 and a floor of $0.28 in Q4 2025.
  • Median Debt to Equity over the past 5 years was $0.79 (2023), compared with a mean of $0.94.
  • Biggest five-year swings in Debt to Equity: crashed 88.28% in 2021 and later surged 159.33% in 2022.
  • Idexx Laboratories' Debt to Equity stood at $1.23 in 2021, then grew by 26.13% to $1.55 in 2022, then plummeted by 69.7% to $0.47 in 2023, then dropped by 17.65% to $0.39 in 2024, then decreased by 27.62% to $0.28 in 2025.
  • The last three reported values for Debt to Equity were $0.28 (Q4 2025), $0.34 (Q3 2025), and $0.71 (Q2 2025) per Business Quant data.